No picture, placeholder image
No picture, placeholder image
Institutt for medisinsk biologi lro037@post.uit.no +4777625182 Tromsø MH L7.229B

Leif R. Rønning


DVM, Stipendiat i kardiovaskulær forskningsgrupppe


  • Lars Rødland, Leif Reidar Brenk Rønning, Anders Benjamin Kildal, Ole-Jakob How:
    The β3 adrenergic receptor antagonist L-748,337 attenuates dobutamine-induced cardiac inefficiency while preserving inotropy in anesthetized pigs
    Journal of Cardiovascular Pharmacology and Therapeutics 23. september 2021 Ekstern lenke
  • Lars Rødland, Leif Reidar Brenk Rønning, Anders Benjamin Kildal, Truls Myrmel, Ole-Jakob How:
    Combined therapy with dobutamine and omecamtiv mecarbil in pigs with ischemic acute heart failure is attributed to the effect of dobutamine
    Journal of Cardiovascular Pharmacology and Therapeutics 2019 Ekstern lenke
  • Leif Reidar Brenk Rønning, Jens Petter Bakkehaug, Lars Rødland, Anders Benjamin Kildal, Truls Myrmel, Ole-Jakob How:
    Opposite diastolic effects of omecamtiv mecarbil versus dobutamine and ivabradine co-treatment in pigs with acute ischemic heart failure
    Physiological Reports 2018 Ekstern lenke
  • Jens Petter Bakkehaug, Anders Benjamin Kildal, Erik Torgersen Engstad, Neoma Tove Boardman, Torvind Næsheim, Leif R. Rønning, Ellen Aasum, Terje Larsen, Truls Myrmel, Ole-Jakob How:
    Myosin activator omecamtiv mecarbil increases myocardial oxygen consumption and impairs cardiac efficiency mediated by resting myosin ATPase activity
    Circulation: Heart Failure 2015 Ekstern lenke
  • Jens Petter Bakkehaug, Anders Benjamin Kildal, Erik Torgersen Engstad, Neoma Tove Boardman, Torvind Næsheim, Leif R. Rønning, Ellen Aasum, Terje Larsen, Truls Myrmel, Ole-Jakob How:
    Response to Letter Regarding Article, "Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity"
    Circulation: Heart Failure 2015 Ekstern lenke
  • Se alle arbeider i Cristin →